Progress, Potential, and Possibilities
Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us Host - Ira S. Pastor
Show episodes
William Taranto - President, Merck Global Health Innovation Fund - Recalibration And Consolidation Of Digital Health In 2024
Bill Taranto is President of both the Merck Global Health Innovation Fund ( MGHIF - https://www.merckghifund.com/ ), and Merck Global Health Private Equity (GHIPE). He is the founder of MGHIF and is responsible for leading the global health capability for Merck ( https://www.merck.com/ ). The Merck Global Health Innova
Captain (ret) Dr. Gurpartap "GP" Sandhoo, Ph.D. is Director, Emerging Technologies and Architectures - Space Sector at Northrop Grumman ( https://www.northropgrumman.com/space ), where he is focused on leveraging new and emerging technologies and manufacturing process to shape the future of civil and national security
Danielle Halstrom, President, GE HealthCare Foundation - Improving Maternal Health Outcomes Globally
Danielle Halstrom is President of the GE HealthCare Foundation ( https://www.gehealthcare.com/foundation ), a philanthropic foundation arm of GE HealthCare that supports nonprofit organizations aimed at making healthcare more accessible, personal, human, and flexible – and ultimately, strives to remove barriers that se
Dr. Sean Kirkpatrick, Ph.D. - Nonlinear Solutions LLC - Science And Technology For Emerging National Security Threats
Dr. Sean Kirkpatrick, Ph.D. is Owner of Nonlinear Solutions LLC., an advisory group that provides strategic scientific and intelligence consulting services, with a focus on emerging science and technology trends, to clients in both the defense and intelligence communities. Dr. Kirkpatrick recently retired from federal
Dr. Tahmeed Ahmed, MD, PhD - Executive Director, icddr,b - Improving Health And Wellbeing Of People In The World’s Poorest Nations
Dr. Tahmeed Ahmed, MD, PhD is Executive Director of the icddr,b ( https://www.icddrb.org/ - formerly known as the International Centre for Diarrhoeal Disease Research, Bangladesh), an organization committed to solving public health problems facing low- and middle-income countries through innovative scientific research
Prof. Dr. Thomas Rademacher, MD, PhD - CEO & Co-Founder, Emergex - T-Cell Priming Immunotherapies To Provide Broad And Robust, Long-Term Immunity
Professor Dr. Thomas Rademacher, MD, PhD, is CEO and Co-Founder of Emergex ( https://emergexvaccines.com/ ), a company that has developed a novel nanoparticle-based vaccine technology to deliver synthetic viral fragments via microneedles on a skin-adhesive patch. Emergex’s approach works on the principle of priming imm
